CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers? experimental drug enters human testing
Disease control TerminatedThis study tested a new drug called NMS-03592088 in adults whose acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) had returned or did not respond to standard treatments. The main goals were to find a safe dose and see if the drug could help control the cance…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Experimental drug aims to tame tough blood cancers
Disease control TerminatedThis study tested a new drug called S227928, both by itself and combined with an existing drug (venetoclax), for people with advanced forms of leukemia and related blood cancers that had stopped responding to standard treatments. The main goals were to find a safe and effective d…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC